Drugs / VGB-Ex01
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT06041620 | Aug 2023 → Dec 2025 | beta-thalassemia major | Institute of Hematology & Blood Diseases Hospital, China | Unknown | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | VGB-Ex01 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06041620 ↗ |